Real-world evidence and insights across disease and therapy areas.
Our syndicated research offers an agile, cost effective approach to providing deep insights based on real world evidence, from both healthcare professionals and patients themselves. Supporting critical commercial decisions across therapy areas globally, our data offers robust insights throughout early pipeline stages and the entire product lifecycle.
Our portfolio includes Therapy Watch and Living With, delivering customized, strategically aligned insights.
Therapy Watch is a syndicated market tracking solution providing real-world evidence on patient profiles, treatment pathways and line of therapy, switching dynamics, drivers and barriers, and patient market share. Physician-driven quantitative data derived from patient records can be used across the Product lifecycle to inform product launch and brand performance.
Living With is a series of disease-specific reports providing a foundational understanding of the patient journey through real-world patient insights. They highlight patients’ emotional needs and treatment challenges for a variety of chronic diseases, to help inform patient-centric clinical and marketing strategies.
Discover how our syndicated research provides agile, customized insights, aligned strategically to evolving therapeutic landscapes and market demands.
PAH treatment is evolving with new therapies like Winrevair, offering fresh hope in a space long defined by unmet medical needs.
Syndicated research redefined—agile, real-world insights tailored to pharma needs with speed, flexibility, and impact.
Integrated research uncovered nuanced patient journeys and treatment shifts to guide clinical strategy and avoid portfolio cannibalization
Explore advances in migraine treatment, patient stories, and insights from research. CGRPs, gepants, and more offer hope but challenges remain.
Rapport is our monthly newsletter where we share our latest expertise and experience.
